Back to results
US 2003/0199503 A1Published application
Compounds and methods for the treatment of prevention of flavivirus infections
AssigneeShire BioChem Inc.
InventorsLaval Chan Chun Kong, Oswy Z. Pereira, Nghe Nguyen-Ba, Thumkunta Jagadeeswar Reddy, Sanjoy Kumar Das, Mohammad Arshad Siddiqui
Life of this patent
Estimating the term…
Abstract
The present invention provides novel compounds represented by formula I: 1 or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.
Claims56
A compound having the formula I:
- 35
- or pharmaceutically acceptable salts thereof,
- wherein,
- X is chosen from
- 36
- n is an integer between 0 and 2
- Y is chosen from COOR5, COCOOR5, P(O)ORaORb, S(O)OR5, S(O)2OR5, an acid bio-isostere, CO-(amino acid), CONRcRd, CON(R4)—SO2—R5 or CONR5OH, wherein R4, R5, Ra, Rb, Rc, and Rd are each independently chosen from H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-12 aryl, C3-10 heterocycle, C3-10 heteroaralkyl, C6-12 aralkyl;
- or Ra and Rb are taken together to form a 5 to 7 membered heterocycle;
- or Rc and Rd are taken together to form a 3 to 10 membered heterocycle;
- W is chosen from O, S or NR6, wherein R6 is chosen from H, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-12 aryl, C3-10 heterocycle, C3-10 heteroaralkyl, C6-12 aralkyl;
- R1 is chosen from C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-12 aryl, C3-10 heterocycle, C3-10 heteroaralkyl, C6-12 aralkyl, C1-12 alkyloxy, C6-12 aryloxy or a halogen;
- R2 is chosen from C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C6-12 aryl, C3-10 heterocycle, C6-12 aralkyl or C3-10 heteroaralkyl;
- R3 is chosen from H, C1-12 alkyl or C6-12 aralkyl;
- With the proviso that:
- iii) when R1 is phenyl and Y is COOCH3 then X is other than NH—CH2-phenyl;
- iv) when R1 is N-morpholino and Y is COOCH3 then X is other than NH— (CO)-phenyl.
13 more elements
A compound chosen from or pharmaceutically acceptable salts:
- 4-[Methyl-(4-methyl-benzoyl)-amino]-2-phenyl-thiazole-5-carboxylic acid;
- 4-[(2,4-Dichloro-benzoyl)-methyl-amino]-2-phenyl-thiazole-5-carboxylic acid;
- 4-[(2,4-Dichloro-benzoyl)-isopropyl-amino]-2-phenyl-thiazole-5-carboxylic acid;
- 4-[(2,4-Dichloro-benzoyl)-ethyl-amino]-2-phenyl-thiazole-5-carboxylic acid;
- 2-Phenyl-4-(toluene-2-sulfonylamino)-thiazole-5-carboxylic acid;
- 4-[Isopropyl-(4-methyl-benzoyl)-amino]-2-phenyl-thiazole-5-carboxylic acid;
- 4-(4-Chloro-benzoylamino)-2-phenyl-thiazole-5-carboxylic acid;
- 4-(2,4-Dimethyl-benzoylamino)-2-phenyl-thiazole-5-carboxylic acid;
- 4-(2,4-Dimethyl-benzenesulfonylamino)-2-phenyl-thiazole-5-carboxylic acid;
- 2-Phenyl-4-(toluene-4-sulfonylamino)-thiazole-5-carboxylic acid;
- 4-(2,4-Dichloro-benzoylamino)-2-phenyl-thiazole-5-carboxylic acid
- 4-(3-Methyl-benzoylamino)-2-phenyl-thiazole-5-carboxylic acid4-[(2-Chloro-benzoyl)-methyl-amino]-2-phenyl-thiazole-5-carboxylic acid;
- 4-[(4-Chloro-benzoyl)-methyl-amino]-2-phenyl-thiazole-5-carboxylic acid;
- 4-[(4-Chloro-benzoylamino]-2-phenyl-thiazole-5-carboxylic acid;
- 4-[(2,4-DIMETHYL-BENZOYL)-METHYL-AMINO]-2-MORPHOLIN-4-YL-THIAZOLE-5-CARBOXYLIC ACID;
- and pharmaceutical acceptable salts thereof.
13 more elements
Dependencies are inferred from the claim text.